Target Name: LOC105377871
NCBI ID: G105377871
Review Report on LOC105377871 Target / Biomarker Content of Review Report on LOC105377871 Target / Biomarker
LOC105377871
Other Name(s): LOC105377871 variant X3 | uncharacterized LOC105377871 | LOC105377871 variant X2 | Uncharacterized LOC105377871, transcript variant X2 | Uncharacterized LOC105377871, transcript variant X3

Exploring the Potential Drug Target and Biomarker LOC105377871

LOC105377871 is a protein that has been identified through various bioinformatics studies as having potential drug targets. Its unique structure and various post-translational modifications have piqued the interest of researchers, who are now trying to determine if LOC105377871 can serve as a biomarker or drug target. In this article, we will delve into the potential drug target and biomarker that LOC105377871 may be.

Potential Drug Target

The identification of potential drug targets is a crucial step in the development of new pharmaceuticals. LOC105377871 has been shown to play a crucial role in various cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of cell cycle progression and apoptosis. Several studies have identified LOC105377871 as a potential drug target.

One of the key reasons for LOC105377871's potential as a drug target is its unique structure. LOC105377871 has a unique N-terminal region that consists of a conserved protein domain and a variable region. The variable region is known to be involved in LOC105377871's unique functions, including its role in cell adhesion and migration.

Another reason for LOC105377871's potential as a drug target is its location on the cell surface. LOC105377871 is expressed in most tissues and cells, including the brain, pancreas, and gastrointestinal tract. This makes it an attractive target for drugs that can cross-talk with cell surface receptors, such as those used to treat anxiety and depression.

Finally, LOC105377871 has been shown to play a role in various diseases, including cancer. Its involvement in cell cycle regulation and apoptosis makes it a potential target for drugs that can inhibit these processes and lead to cell death in cancer cells.

Biomarker

LOC105377871 has also been identified as a potential biomarker for several diseases, including cancer. Its unique structure and various post-translational modifications make it an attractive target for diagnostic tools, such as mass spectrometry-based assays.

One of the key advantages of using LOC105377871 as a biomarker is its ease of extraction and purification. Its unique structure allows it to be easily isolated from various tissues and cell fractions, making it a promising candidate for diagnostic applications.

Another advantage of LOC105377871 is its stability. The protein has been shown to be stable under various conditions, including high temperature and the presence of inhibitors. This stability makes it a potential candidate for diagnostic applications that require long-term stability, such as cancer diagnosis.

Conclusion

LOC105377871 is a protein with unique structure and post-translational modifications that has potential as a drug target and biomarker. Its involvement in various cellular processes and its location on the cell surface make it an attractive target for drugs that can inhibit its functions. Further research is needed to determine if LOC105377871 can serve as a reliable drug target and biomarker for various diseases.

Protein Name: Uncharacterized LOC105377871

The "LOC105377871 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377871 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003